US stock futures drop as Trump imposes sweeping new tariffs
July's jobs report is due at 8:30 a.m. ET and is expected to show the economy added 100,000 jobs, according to a Dow Jones survey of economists. The unemployment rate is seen edging up to 4.2% from 4.1% in June.
Such a jobs report would be considered a 'Just Right' labor market, said Tom Essaye, founder of Sevens Report Research. It would "further push back on growing tariff-relatedrecession concerns, keep the Fed on track for a rate cut in September and further invalidate the stagflation narrative." It also would provide stocks with a reason to extend their recent rally, he said.
Meanwhile, Trump signed an executive order confirming 'reciprocal' tariffs on dozens of countries, with updated duties ranging from 10% to 41%, beginning in seven days. He also said goods that switch means of transport, or are transshipped, to avoid tariffs will face another 40% tax.
Starting Aug. 1, Canada will face a 35% tariff, excluding goods compliant with the Canada-U.S.-Mexico Agreement on trade. That's up from 25% previously.
Countries that are not listed in the latest order will face an additional duty of 10%, the statement said.
Earlier, Trump said he's giving Mexico another 90 days to come to a longer term agreement with the United States to avoid higher tariffs.
At 6:15 a.m. ET, futures tied to the blue-chip Dow fell -0.95%, broad S&P 500 futures slipped -0.97% and tech-heavy Nasdaq futures dropped -1.10%.
Corporate news
Earnings also continue to be key in determining stock market direction. Of the 297 companies in the S&P 500 that have reported earnings through the morning of July 31, 80.8% have topped analyst expectations, according to LSEG Data and Analytics, compared with the 76% beat rate over the past four quarters.
After the market closed, Amazon and Apple -- two so-called Magnificent Seven influential, mega cap tech stocks -- reported results.
Amazon topped Wall Street estimates with its second-quarter results, but its cloud computing growth was disappointing.
In contrast, Apple exceeded second-quarter expectations, including the largest revenue jump since 2021. Sales were helped by strong 13%-plus growth in iPhone sales due to tariff-related buying and popular devices. It projected tariff costs could reach $1.1 billion in the current quarter.
Among non-Magnificent Seven stocks,
Medora Lee is a money, markets, and personal finance reporter at USA TODAY. You can reach her at mjlee@usatoday.com and subscribe to our free Daily Money newsletter for personal finance tips and business news every Monday through Friday morning.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
MOGU Full Year 2025 Earnings: CN¥7.14 loss per share (vs CN¥6.85 loss in FY 2024)
Explore MOGU's Fair Values from the Community and select yours MOGU (NYSE:MOGU) Full Year 2025 Results Key Financial Results Revenue: CN¥141.2m (down 12% from FY 2024). Net loss: CN¥62.6m (loss widened by 5.5% from FY 2024). CN¥7.14 loss per share (further deteriorated from CN¥6.85 loss in FY 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period MOGU shares are down 2.9% from a week ago. Risk Analysis You should always think about risks. Case in point, we've spotted 1 warning sign for MOGU you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
10 minutes ago
- Yahoo
Sohu.com Second Quarter 2025 Earnings: US$0.69 loss per share (vs US$1.16 loss in 2Q 2024)
Explore Fair Values from the Community and select yours (NASDAQ:SOHU) Second Quarter 2025 Results Key Financial Results Revenue: US$126.3m (down 27% from 2Q 2024). Net loss: US$20.0m (loss narrowed by 47% from 2Q 2024). US$0.69 loss per share (improved from US$1.16 loss in 2Q 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Earnings Insights Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 10% growth forecast for the Entertainment industry in the US. Performance of the American Entertainment industry. The company's shares are down 3.4% from a week ago. Risk Analysis You should always think about risks. Case in point, we've spotted 1 warning sign for you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
10 minutes ago
- Yahoo
Krystal Biotech Second Quarter 2025 Earnings: Beats Expectations
Explore Krystal Biotech's Fair Values from the Community and select yours Krystal Biotech (NASDAQ:KRYS) Second Quarter 2025 Results Key Financial Results Revenue: US$96.0m (up 37% from 2Q 2024). Net income: US$38.3m (up 146% from 2Q 2024). Profit margin: 40% (up from 22% in 2Q 2024). The increase in margin was driven by higher revenue. EPS: US$1.33 (up from US$0.54 in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Krystal Biotech Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) also surpassed analyst estimates by 14%. Looking ahead, revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Biotechs industry in the US. Performance of the American Biotechs industry. The company's shares are down 12% from a week ago. Risk Analysis It is worth noting though that we have found 1 warning sign for Krystal Biotech that you need to take into consideration. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.